Case Study: Eflornithine and the African Sleeping Sickness. The central issue of this case study is what should be done with mounting pressures to give up our company's patent on eflornithine, a drug that can cure Human African trpanosomiasis, more commonly known as African Sleeping Sickness, a disease that attacks the nervous system. Pages: 4 Bibliography: 1 source(s) listed Filename: 13734 African Sleeping Sickness.doc Price: 35.80